Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.01 USD | +1.94% | +6.90% | +13.66% |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
May. 07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.